DarioHealth Corp. (NASDAQ:DRIO) Short Interest Down 17.3% in January

DarioHealth Corp. (NASDAQ:DRIO) saw a large drop in short interest in January. As of January 30th, there was short interest totaling 64,677 shares, a drop of 17.3% from the January 15th total of 78,193 shares. Approximately 1.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 7,270 shares, the short-interest ratio is presently 8.9 days. Based on an average daily trading volume, of 7,270 shares, the short-interest ratio is presently 8.9 days. Approximately 1.0% of the shares of the stock are short sold.

Institutional Trading of DarioHealth

A number of institutional investors and hedge funds have recently modified their holdings of DRIO. Kestra Advisory Services LLC bought a new position in shares of DarioHealth during the fourth quarter valued at $35,000. Geode Capital Management LLC grew its stake in shares of DarioHealth by 167.9% in the fourth quarter. Geode Capital Management LLC now owns 49,567 shares of the company’s stock worth $564,000 after acquiring an additional 31,063 shares during the period. Finally, XTX Topco Ltd lifted its position in DarioHealth by 229.0% during the second quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock valued at $42,000 after purchasing an additional 43,513 shares during the period. Institutional investors own 33.39% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on DRIO shares. Wall Street Zen cut shares of DarioHealth from a “hold” rating to a “sell” rating in a research report on Sunday, January 25th. Stifel Nicolaus set a $16.00 target price on shares of DarioHealth in a research note on Friday, November 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of DarioHealth in a research note on Monday, December 29th. Finally, TD Cowen reaffirmed a “hold” rating on shares of DarioHealth in a research report on Friday, November 14th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $38.00.

DarioHealth Stock Up 4.2%

DarioHealth stock traded up $0.47 during mid-day trading on Monday, reaching $11.72. The stock had a trading volume of 10,343 shares, compared to its average volume of 18,092. DarioHealth has a one year low of $5.93 and a one year high of $17.74. The company has a 50-day moving average price of $11.41 and a two-hundred day moving average price of $11.68. The company has a market capitalization of $79.23 million, a price-to-earnings ratio of -1.05 and a beta of 1.16. The company has a debt-to-equity ratio of 0.41, a current ratio of 4.55 and a quick ratio of 4.02.

About DarioHealth

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.